This section will contain updates from the pain industry.

KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of APADAZ®

 KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug Application (sNDA) for two additional strengths of APADAZ ® , an immediate release (IR) combination of KemPharm...
Continue reading

AAPMF Pain Medicine Education Program for Daiichi Sankyo Reps

The AAPM Foundation has launched a pain medicine education program (PMEP) specifically designed for 300 Daiichi Sankyo sales representatives. The course aims to further representatives' knowledge, confidence, and credibility when interacting with pain medicine healthcare providers. Watch for the PMEP emblem on the business cards of DSI representati...
Continue reading